Lee Jonghyun, Park Yong Bo, Han Sung Yong, Joo Dong Chan, Hong Seung Min, Yi Kiyoun, Kim Dong Uk
Division of Gastroenterology, Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea.
Department of Internal Medicine, College of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
J Clin Med. 2024 May 30;13(11):3226. doi: 10.3390/jcm13113226.
: Endoscopic papillectomy (EP) is the preferred treatment for ampullary tumors because it has fewer side effects than surgical removal. This study retrospectively compared a new anchoring EP method (A-EP) with the conventional (C-EP) approach. : Ninety-nine patients who underwent EP at a single medical institution between 2009 and 2021 were retrospectively reviewed. In all patients, the indications for EP were pathological adenoma with <10 mm of biliary invasion and a tumor diameter <30 mm on endoscopic ultrasonography. The exclusion criteria were antiplatelet/anticoagulant use, previous upper GI surgery, or prior biliary/pancreatic endoscopic therapy. One expert endoscopist performed the two types of EPs, A-EP and C-EP. : Sixty-two patients underwent A-EP, and 37 underwent C-EP. There were no significant differences in baseline characteristics, such as sex, age, tumor size, and ductal invasion on endoscopic ultrasound. The A-EP group had higher en bloc resection rates (95.2% vs. 78.4%, = 0.010). Although the difference was not statistically significant, it tended towards fewer incidences of pancreatitis ( = 0.081) and duct stricture ( = 0.081). The recurrence rate was lower in the A-EP group (8.1% vs. 37.8%, = 0.000). There were no significant differences between the two groups regarding the follow-up period (A-EP vs. C-EP, 725 vs. 1045 days, = 0.109) or the days of recurrence (A-EP vs. C-EP, 341 vs. 562 days, = 0.551). : A-EP showed better outcomes than C-EP in terms of en bloc resection and recurrence rates, providing evidence for the efficacy of this novel EP method.
内镜乳头切除术(EP)是壶腹肿瘤的首选治疗方法,因为它比手术切除的副作用更少。本研究回顾性比较了一种新的锚定EP方法(A-EP)与传统(C-EP)方法。:回顾性分析了2009年至2021年在单一医疗机构接受EP治疗的99例患者。所有患者的EP指征为病理诊断为腺瘤、胆管侵犯<10mm且内镜超声检查肿瘤直径<30mm。排除标准为使用抗血小板/抗凝药物、既往上消化道手术或既往胆管/胰腺内镜治疗。由一名专家内镜医师进行两种类型的EP,即A-EP和C-EP。:62例患者接受了A-EP,37例接受了C-EP。在内镜超声检查的基线特征方面,如性别、年龄、肿瘤大小和胆管侵犯情况,两组之间无显著差异。A-EP组的整块切除率更高(95.2%对78.4%,P = 0.010)。虽然差异无统计学意义,但胰腺炎(P = 0.081)和胆管狭窄(P = 0.081)的发生率有减少的趋势。A-EP组的复发率较低(8.1%对37.8%,P = 0.000)。两组在随访时间(A-EP对C-EP,725天对1045天,P = 0.109)或复发天数(A-EP对C-EP,341天对562天,P = 0.551)方面无显著差异。:A-EP在整块切除率和复发率方面显示出比C-EP更好的结果,为这种新型EP方法的疗效提供了证据。